The focus of this project is the analysis of multistage neoplastic change in B-cell lymphomas induced in the bursa of Fabricius by myc oncogenes. A central experimental strategy involves retroviral gene transfer into bursal stem cells used to reconstitute ablated embryonic bursal follicles. This approach, together with related techniques, allows further insight into the roles in bursal lymphomagenesis of apoptiotic cell death, cell cycle control, genetic instability, and the genes which regulate these processes-including a novel gene we have detected, CTCF, which can regulate myc expression.
Our specific aims are: (1) We will analyze the biological function of CTCF by determining the phenotypic consequences of CTCF overexpression and inhibition in normal fibroblasts, cultured B-cell lines, cultured bone marrow and in normal and neoplastic B-cell development in vivo. (2) We will block apoptotic cell death in normal and preneoplastic bursal follicles by constitutive overexpression of NR-13 and/or other cell death regulatory genes. In this fashion, we will learn more about the role of all death in both normal and neoplastic bursal development. (3) We will analyze the relationship between surface immunoglobulin (Ig) diversification, apoptotic cell death and cellular proliferation, in normal and neoplastic bursal B-cells. These studies involve observation of the effects of constitutive expression of germline Ig surface molecules in bursal stem cells and their normal, preneoplastic and neoplastic progeny. (4) We will determine whether bic can act as a cooperating oncogene in the generation of myc-initiated B-cell lymphoma and will explore the mechanisms underlying activation of bic expression in these tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA020068-22
Application #
2700322
Study Section
Pathology B Study Section (PTHB)
Program Officer
Cole, John S
Project Start
1976-03-01
Project End
2001-04-30
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
22
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Neiman, Paul E; Elsaesser, Katrina; Loring, Gilbert et al. (2008) Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis. PLoS Genet 4:e1000132
Kimmel, Robert R; Agnani, Shivali; Yang, Yin et al. (2008) DNA copy-number instability in low-dose gamma-irradiated TK6 lymphoblastoid clones. Radiat Res 169:259-69
Kimmel, Robert R; Zhao, Lue Ping; Nguyen, Doan et al. (2006) Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer. Radiat Res 166:519-31
Neiman, P E; Kimmel, R; Icreverzi, A et al. (2006) Genomic instability during Myc-induced lymphomagenesis in the bursa of Fabricius. Oncogene 25:6325-35
Neiman, Paul E; Burnside, Joan; Elsaesser, Katrina et al. (2006) Analysis of gene expression, copy number and palindrome formation with a Dt40 enriched cDNA microarray. Subcell Biochem 40:245-56
Burnside, Joan; Neiman, Paul; Tang, Jianshan et al. (2005) Development of a cDNA array for chicken gene expression analysis. BMC Genomics 6:13
Brown, Cheryl Y; Bowers, Sandra J; Loring, Gibert et al. (2004) Role of Mtd/Bok in normal and neoplastic B-cell development in the bursa of Fabricius. Dev Comp Immunol 28:619-34
Parghi, Sean S; Brandvold, Kimberly A; Bowers, Sandra J et al. (2004) Reduced Myc overexpression and normal B-cell differentiation mediate resistance to avian leukosis virus lymphomagenesis. Oncogene 23:4413-21
Black, Elizabeth J; Clair, Timothy; Delrow, Jeffrey et al. (2004) Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun. Oncogene 23:2357-66
Cheng, Chun; Kimmel, Robert; Neiman, Paul et al. (2003) Array rank order regression analysis for the detection of gene copy-number changes in human cancer. Genomics 82:122-9

Showing the most recent 10 out of 42 publications